Literature DB >> 24770791

An unusual case of familial adenomatous polyposis with very early symptom occurrence.

Maurizio Ponz de Leon1, Maria Anastasia Bianchini, Luca Reggiani-Bonetti, Monica Pedroni, Carmela Di Gregorio, Alberto Merighi, Giuseppina Rossi, Giulia Magnani, Federica Domati, Alfredo Cacciari.   

Abstract

We report the clinical case of a patient who showed an "accelerated" form of polyposis, with development of major lesions within the first decade of life. The patient belongs to a familial adenomatous polyposis family-already described in 2001-featured by profuse polyposis at an early age of onset and desmoid tumors in the majority of affected individuals (of both sexes). The family was characterized by an uncommon mutation of the APC gene (c.4391_4700del310insCACCTACTGCTGAAA, previously defined as c.4394ins15del310) consisting in a large deletion of 310 bp at codon 1,464 with duplication of the breakpoint leading to a stop codon at position 1,575. The proband was affected by desmoids tumors at the age of 3 years. In the same year (2004) numerous polyps in the large bowel and a hepatoblastoma developed. After several months new desmoids appeared in the surgical scar. In 2010, at age 9, the patient was operated of total colectomy and endorectal pull-through of the small intestine owing to profuse colorectal adenomatosis. New desmoids developed in 2011 and 2012, and required chemotherapy. Further analysis of the APC gene in the proband revealed several polymorphisms. One of these (c.398A>G) had not been previously reported, nor was present in two other affected members of the family. The clinical case, and the practical implications for therapy, are discussed according to the most recent theories of colorectal cancer development. Long-term treatment with Cox-2 inhibitors might represent a good option for this patient.

Entities:  

Mesh:

Year:  2014        PMID: 24770791     DOI: 10.1007/s10689-014-9718-3

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  24 in total

1.  Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in Lynch syndrome.

Authors:  Bente A Talseth-Palmer; Ingvild S Brenne; Katie A Ashton; Tiffany-Jane Evans; Mary McPhillips; Claire Groombridge; Janina Suchy; Grzegorz Kurzawski; Allan Spigelman; Jan Lubinski; Rodney J Scott
Journal:  J Med Genet       Date:  2010-11-19       Impact factor: 6.318

Review 2.  The p53 tumor suppressor gene.

Authors:  A J Levine; A Chang; D Dittmer; D A Notterman; A Silver; K Thorn; D Welsh; M Wu
Journal:  J Lab Clin Med       Date:  1994-06

3.  The safety and efficacy of celecoxib in children with familial adenomatous polyposis.

Authors:  Patrick M Lynch; Gregory D Ayers; Ernie Hawk; Ellen Richmond; Craig Eagle; Mabel Woloj; James Church; Hennie Hasson; Sherri Patterson; Elizabeth Half; Carol A Burke
Journal:  Am J Gastroenterol       Date:  2010-03-16       Impact factor: 10.864

4.  Biallelic MLH1 SNP cDNA expression or constitutional promoter methylation can hide genomic rearrangements causing Lynch syndrome.

Authors:  Monika Morak; Udo Koehler; Hans Konrad Schackert; Verena Steinke; Brigitte Royer-Pokora; Karsten Schulmann; Matthias Kloor; Wilhelm Höchter; Josef Weingart; Cortina Keiling; Trisari Massdorf; Elke Holinski-Feder
Journal:  J Med Genet       Date:  2011-06-28       Impact factor: 6.318

Review 5.  Biology of the adenomatous polyposis coli tumor suppressor.

Authors:  K H Goss; J Groden
Journal:  J Clin Oncol       Date:  2000-05       Impact factor: 44.544

Review 6.  Familial adenomatous polyposis.

Authors:  Polymnia Galiatsatos; William D Foulkes
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

7.  A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis.

Authors:  R K S Phillips; M H Wallace; P M Lynch; E Hawk; G B Gordon; B P Saunders; N Wakabayashi; Y Shen; S Zimmerman; L Godio; M Rodrigues-Bigas; L-K Su; J Sherman; G Kelloff; B Levin; G Steinbach
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

8.  Colorectal cancer surveillance behaviors among members of typical and attenuated FAP families.

Authors:  Anita Y Kinney; Bret Hicken; Sara E Simonsen; Vickie Venne; Katrina Lowstuter; Jonathan Balzotti; Randall W Burt
Journal:  Am J Gastroenterol       Date:  2007-01       Impact factor: 10.864

9.  Integrated analysis of unclassified variants in mismatch repair genes.

Authors:  Chiara Pastrello; Elisa Pin; Fabio Marroni; Chiara Bedin; Mara Fornasarig; Maria Grazia Tibiletti; Cristina Oliani; Maurizio Ponz de Leon; Emanuele Damiano Urso; Lara Della Puppa; Marco Agostini; Alessandra Viel
Journal:  Genet Med       Date:  2011-02       Impact factor: 8.822

10.  Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry.

Authors:  Jenny N Poynter; Jane C Figueiredo; David V Conti; Kathleen Kennedy; Steven Gallinger; Kimberly D Siegmund; Graham Casey; Stephen N Thibodeau; Mark A Jenkins; John L Hopper; Graham B Byrnes; John A Baron; Ellen L Goode; Maarit Tiirikainen; Noralane Lindor; John Grove; Polly Newcomb; Jeremy Jass; Joanne Young; John D Potter; Robert W Haile; David J Duggan; Loic Le Marchand
Journal:  Cancer Res       Date:  2007-12-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.